| Direct Competitor Comparison | |
|---|
| JNJ | COV | NVS | PFE | Industry |
|---|
| Market Cap: | 248.47B | 30.70B | 183.36B | 207.83B | 64.52B |
|---|
| Employees: | 127,600 | 43,400 | 129,000 | 89,400 | 99.49k |
|---|
| Qtrly Rev Growth (yoy): | 0.09 | 0.05 | 0.02 | -0.09 | 0.11 |
|---|
| Revenue (ttm):
| 68.59B | 12.17B | 57.80B | 57.60B | 27.01B |
|---|
| Gross Margin (ttm): | 0.68 | 0.57 | 0.68 | 0.81 | 0.61 |
|---|
| EBITDA (ttm): | 21.74B | 3.29B | 17.15B | 25.34B | 10.37B |
|---|
| Operating Margin (ttm):
| 0.26 | 0.22 | 0.22 | 0.32 | 0.16 |
|---|
| Net Income (ttm): | 10.44B | 1.85B | 9.66B | 10.52B | N/A |
|---|
| EPS (ttm): | 3.68 | 3.85 | 3.94 | 2.09 | 3.27 |
|---|
| P/E (ttm): | 24.02 | 16.95 | 18.94 | 14.03 | 14.20 |
|---|
| PEG (5 yr expected): | 2.56 | 2.19 | 2.76 | 4.78 | 0.96 |
|---|
| P/S (ttm): | 3.60 | 2.52 | 3.17 | 3.61 | 2.23 |
|---|
|
| COV = Covidien plc | | NVS = Novartis AG | | PFE = Pfizer Inc. | | Industry = Drug Manufacturers - Major | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 104.53 | 0.00 | 78.39B | 17.69 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 233.07 | 0.00 | 55.32B | 36.98 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 55.93 | 0.00 | 85.31B | 31.32 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 74.10 | 0.00 | 12.75B | 31.37 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.35 | 0.00 | 33.53B | 19.65 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 130.04 | 0.00 | 16.61B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.55 | 0.00 | 12.02B | 21.08 |
|---|
| Pfizer Inc. | PFE | 29.30 | 0.00 | 207.83B | 14.03 |
|---|
| Johnson & Johnson | JNJ | 88.46 | 0.00 | 248.47B | 24.02 |
|---|
| GlaxoSmithKline plc | GSK | 52.94 | 0.00 | 128.22B | 19.35 |
|---|
| Sanofi | SNY | 55.05 | 0.00 | 145.70B | 27.13 |
|---|
| Novartis AG | NVS | 74.62 | 0.00 | 183.36B | 18.94 |
|---|
| Roche Holding AG | RHHBY | 65.65 | 0.00 | 222.81B | 21.97 |
|---|
| AstraZeneca PLC | AZN | 52.35 | 0.00 | 65.44B | 11.58 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.72 | 0.00 | 58.80B | 11.50 |
|---|
| Bristol-Myers Squibb Company | BMY | 46.40 | 0.00 | 76.21B | 52.55 |
|---|
|
| News on Direct Competitors | |
|---|
Currency in USD. | |
|
1.93%